KeyBanc Maintains CareTrust REIT Inc(CTRE.US) With Buy Rating, Maintains Target Price $40
KeyBanc has reiterated its Buy rating for CareTrust REIT Inc (CTRE.US) and maintained its target price at $40. This indicates a continued positive outlook from the firm regarding the company's stock performance.
CareTrust REIT Announces $119 Million of Recent Investments; Reloaded Pipeline
CareTrust REIT announced the closing of two new investments totaling $119 million, effective April 1, 2026. These investments include a senior housing and skilled nursing campus in Southern California and a mortgage loan for five skilled nursing communities in the Midwest. Combined with a February acquisition in the UK, CareTrust's year-to-date investments for 2026 reached $364 million, with a reloaded pipeline of $500 million in near-term opportunities.
CTRE PE Ratio & Valuation, Is CTRE Overvalued
CareTrust REIT Inc (CTRE) is currently deemed overvalued, with its shares trading at $38.32, which is 27.11% higher than its calculated fair price range of $20.35 to $30.15. The analysis highlights CTRE's forward PS ratio of 14.28 as overvalued compared to its five-year average of 371.08, despite robust revenue growth. The article also provides current and historical valuation metrics like P/B ratio and FCF yield, further supporting the overvalued assessment.
CareTrust REIT, Inc. Experiences Revision in Its Stock Evaluation Amid Market Fluctuations
CareTrust REIT, Inc. has seen its stock valuation adjusted, with its current price at $37.13. The company has delivered a 30.37% return over the past year, outperforming the S&P 500, despite short-term challenges. Key metrics include a P/E ratio of 29 and a strong dividend yield, though its valuation presents a mixed picture when compared to competitors in the realty sector.
Allspring Global Investments Holdings LLC Purchases 112,035 Shares of CareTrust REIT, Inc. $CTRE
Allspring Global Investments Holdings LLC significantly increased its stake in CareTrust REIT, Inc. by 31.3% in the fourth quarter, purchasing an additional 112,035 shares, bringing its total to 470,060 shares valued at approximately $17.07 million. This move is accompanied by CareTrust REIT's recent dividend increase to $0.39 per share, resulting in an annualized yield of 4.1%. The stock currently holds a "Buy" consensus rating from analysts with an average price target of $42.82.
Mizuho Securities Initiates CareTrust REIT Inc(CTRE.US) With Buy Rating, Announces Target Price $42
Mizuho Securities has initiated coverage on CareTrust REIT Inc (CTRE.US) with a "Buy" rating and set a target price of $42. Analyst Vikram Malhotra, who has a 50% success rate and a 0.9% average return over the past year, provided this rating. The report stresses that this information is for educational purposes only and not investment advice.
Mizuho Securities Initiates CareTrust REIT Inc(CTRE.US) With Buy Rating, Announces Target Price $42
Mizuho Securities has initiated coverage on CareTrust REIT Inc (CTRE.US) with a Buy rating. The firm also announced a target price of $42 for the company's shares. This indicates a positive outlook from Mizuho Securities on CareTrust REIT's future performance.
CareTrust REIT acquires skilled nursing facilities portfolio for ~$146M
CareTrust REIT has acquired a portfolio of three skilled nursing facilities in North Carolina for approximately $146 million. This acquisition adds 420 beds to their portfolio and is expected to be immediately accretive to the company's earnings. The facilities will be operated by an existing CareTrust tenant, enhancing their strategic partnership.
CareTrust REIT acquires skilled nursing facilities portfolio for ~$146M
The provided content is empty, so a summary cannot be generated.
CareTrust REIT Inc To Go Ex-Dividend On March 31st, 2026 With 0.39 USD Dividend Per Share
CareTrust REIT Inc (CTRE) is scheduled to go ex-dividend on March 31st, 2026, with a dividend payout of $0.39 per share. Investors must own shares before this date to be eligible for the upcoming dividend. This announcement signals an upcoming distribution of profits to shareholders.
CareTrust REIT, Inc. (NYSE:CTRE) Receives Consensus Recommendation of "Buy" from Brokerages
CareTrust REIT, Inc. (NYSE:CTRE) has received a consensus "Buy" recommendation from twelve brokerages, with an average 12-month target price of $42.90. The company recently increased its quarterly dividend to $0.39, reported strong Q4 earnings, and provided positive FY2026 guidance. Institutional ownership remains high, with major funds significantly increasing their stakes.
CareTrust REIT Inc (STU:7XC) Stock Price, Trades & News
This article provides a comprehensive financial overview of CareTrust REIT Inc (STU:7XC), detailing its stock price, trading information, and various financial metrics. It includes performance ranks for financial strength, growth, momentum, profitability, and valuation, alongside key statistics and upcoming financial events. The article also mentions recent news and press releases related to the company, such as dividend increases and acquisition details.
CareTrust REIT, Inc. Experiences Evaluation Revision Amidst Shifting Market Dynamics
CareTrust REIT, Inc. has revised its evaluation due to changing market dynamics, with its stock price now at $37.45. Despite a -6.66% return over the past week, the company has outperformed the S&P 500 over one and three years, showing resilience. Technical indicators are mixed, reflecting current market volatility.
Analysts Offer Insights on Real Estate Companies: CareTrust REIT (CTRE) and Diamondrock (DRH)
Two analysts have issued bullish sentiments on Real Estate sector companies CareTrust REIT (CTRE) and Diamondrock (DRH). Wells Fargo maintained a Buy rating on CTRE with a $42.00 price target, and Truist Financial maintained a Buy rating on DRH with a $9.44 price target. CTRE has a "Strong Buy" consensus with an average price target of $44.00, while DRH has a "Moderate Buy" consensus with a $10.22 price target.
Analysts Offer Insights on Real Estate Companies: CareTrust REIT (CTRE) and Diamondrock (DRH)
Two analysts have provided bullish insights on Real Estate companies CareTrust REIT (CTRE) and Diamondrock (DRH). Wells Fargo maintained a Buy rating on CareTrust REIT with a $42.00 price target, while Truist Financial maintained a Buy rating on Diamondrock with a $9.44 price target. CareTrust REIT also recently raised its quarterly dividend.
CareTrust REIT (NYSE:CTRE) Cut to "Strong Sell" at Zacks Research
Zacks Research has downgraded CareTrust REIT (CTRE) from a "hold" to a "strong sell," despite the analyst consensus remaining a "Buy" with a $42.90 average target price. The company recently exceeded quarterly EPS estimates and issued positive FY2026 guidance. Institutional investors have been actively adjusting their positions in CTRE.
Vanguard disaggregates holdings; subsidiaries to report CTRE separately (CTRE)
Vanguard Group has amended its Schedule 13G/A filing for CareTrust REIT Inc (CTRE), reporting zero beneficial ownership of common stock. This change is due to an internal realignment effective January 12, 2026, where Vanguard disaggregated certain subsidiaries and business divisions, which will now report their holdings separately. This administrative filing clarifies reporting attribution rather than indicating a market sale.
Wells Fargo Maintains CareTrust REIT Inc(CTRE.US) With Buy Rating, Raises Target Price to $42
Wells Fargo analyst John Kilichowski has reiterated a "Buy" rating for CareTrust REIT Inc (CTRE.US) and increased the target price from $41 to $42. Kilichowski boasts a 53.2% success rate and an average return of 5.8% over the past year, according to TipRanks data. This rating adjustment suggests continued confidence in the company's performance.
CTRE: Wells Fargo Raises Price Target to $42, Maintains Overweig
Wells Fargo analyst John Kilichowski has raised the price target for CareTrust REIT (CTRE) from $41.00 to $42.00, reiterating an Overweight rating. This follows several other analysts who have also recently increased price targets and maintained positive ratings for CTRE. The average one-year price target from 11 analysts forecasts a 15.84% upside from the current price, indicating an "Outperform" status based on consensus recommendations.
Wells Fargo & Company Forecasts Strong Price Appreciation for CareTrust REIT (NYSE:CTRE) Stock
Wells Fargo & Company has increased its price target for CareTrust REIT (CTRE) to $42 from $41, maintaining an "overweight" rating and suggesting an 11.57% upside. This aligns with a generally bullish analyst sentiment, with an average target price of $42.90 across several firms. CareTrust REIT recently surpassed quarterly EPS expectations and provided optimistic FY2026 guidance, trading at approximately $37.64 with a market capitalization of $8.40 billion.
CareTrust REIT, Inc. $CTRE Shares Acquired by SG Americas Securities LLC
SG Americas Securities LLC significantly increased its holdings in CareTrust REIT, Inc. by 737% in the fourth quarter, now owning 865,129 shares valued at over $31 million. Other institutional investors also adjusted their positions in the company. CareTrust REIT recently raised its quarterly dividend to $0.39 per share, annualizing to $1.56, and reported strong Q4 earnings, beating analyst estimates.
Is CareTrust REIT’s (CTRE) Bigger Dividend Payout Reframing Its Senior Care Growth Ambitions?
CareTrust REIT recently increased its quarterly dividend from US$0.335 to US$0.39 per share, signaling management's confidence in its cash generation and commitment to shareholders. This move, alongside a US$1.0 billion equity program, aims to support both higher payouts and continued expansion into skilled nursing, seniors housing, and UK care homes. However, investors should consider how this dividend strategy interacts with the company's growth plans, which rely heavily on acquisitions and involve integration and regulatory risks.
Is CareTrust REIT’s (CTRE) Bigger Dividend Payout Reframing Its Senior Care Growth Ambitions?
CareTrust REIT (CTRE) recently increased its quarterly dividend, signaling management's confidence in cash generation and commitment to shareholders. This move, alongside a new equity program, aims to support higher payouts while funding expansion in skilled nursing, seniors housing, and UK care homes. The article suggests this dividend increase doesn't significantly alter the balance between growth through acquisitions and risks like G&A spending and reimbursement, while forecasting substantial revenue and earnings growth for the REIT.
Pensionfund PDN Purchases New Holdings in CareTrust REIT, Inc. $CTRE
Pensionfund PDN has acquired a new position in CareTrust REIT (CTRE), purchasing 41,000 shares valued at approximately $1.48 million in the fourth quarter. Other institutional investors have also adjusted their holdings, with hedge funds and institutional investors now owning 87.77% of the stock. CareTrust REIT has received positive analyst ratings, a consensus "Buy" rating, and a target price of $42.80, alongside a recent dividend increase and a strong earnings beat.
A Look At CareTrust REIT (CTRE) Valuation After The Latest Dividend Increase
CareTrust REIT (CTRE) recently increased its quarterly dividend from US$0.335 to US$0.39 per common share, drawing investor attention despite recent share price declines. The company is considered 17.6% undervalued with a fair value of $43.82 per share, supported by an expanded investment pipeline of approximately $600 million. While historical long-term returns have been strong, investors are advised to consider key risks and a full analysis to determine investment suitability.
CareTrust REIT, Inc. (NYSE:CTRE) Short Interest Up 23.4% in February
CareTrust REIT, Inc. (NYSE:CTRE) experienced a significant 23.4% increase in short interest in February, reaching 15,336,179 shares. Institutional investors hold a substantial 87.77% of CTRE shares, with major increases in stakes from Vanguard, T. Rowe Price, and Invesco, and a new position from Norges Bank. Despite the increased short interest, the company recently announced a higher quarterly dividend of $0.39 per share, an annualized yield of 3.9%, and provided positive FY2026 EPS guidance.
Mirabella Financial Services LLP Acquires 40,962 Shares of CareTrust REIT, Inc. $CTRE
Mirabella Financial Services LLP significantly increased its stake in CareTrust REIT, purchasing 40,962 additional shares, bringing their total holdings to 75,297 shares valued at $2.61 million. This comes as other major institutional investors also boosted their positions in the company. CareTrust REIT recently raised its quarterly dividend, reported strong earnings beating analyst expectations, and received multiple "Buy" ratings and price target increases from brokerages, resulting in a consensus target price of $42.80.
Lighthouse Investment Partners LLC Sells 77,000 Shares of CareTrust REIT, Inc. $CTRE
Lighthouse Investment Partners LLC reduced its stake in CareTrust REIT, Inc. (NYSE:CTRE) by 28.2% in the third quarter, selling 77,000 shares and now owning 196,000 shares valued at $6.797 million. Several other institutional investors also adjusted their holdings in the company. CareTrust REIT recently increased its quarterly dividend to $0.39 per share and has an average analyst rating of "Buy" with a consensus price target of $42.80.
CTRE - Caretrust Latest Stock News & Market Updates
This page provides investors and traders with the latest news, updates, and insights on CareTrust REIT (CTRE), a healthcare-focused real estate investment trust. It includes information on the company's acquisitions, capital markets activity, financial results, dividend declarations, and corporate updates. Recent news highlights include a quarterly dividend announcement of $0.25 per share and strong Q1 2020 operating results.
Algert Global LLC Raises Holdings in CareTrust REIT, Inc. $CTRE
Algert Global LLC has increased its stake in CareTrust REIT, Inc. (NYSE:CTRE) by 16.3% in the third quarter, bringing its total holdings to 266,943 shares valued at approximately $9.26 million. Other significant institutional investors, including Vanguard Group Inc. and State Street Corp, also modified their holdings. Analysts have a "Buy" rating on CTRE and a consensus price target of $42.80, with the company recently increasing its quarterly dividend.
Boothbay Fund Management LLC Increases Stake in CareTrust REIT, Inc. $CTRE
Boothbay Fund Management LLC significantly increased its stake in CareTrust REIT, Inc. by 110.5% in the third quarter, now owning 296,792 shares valued at approximately $10.29 million. CareTrust REIT recently raised its quarterly dividend to $0.39, resulting in an annualized dividend of $1.56, with analysts showing increased optimism, multiple upgrades, and an average target price of $42.80. The company reported strong financial results, beating EPS estimates, and has a market capitalization of $8.93 billion.
How CareTrust REIT’s Higher Quarterly Dividend Will Impact CareTrust REIT (CTRE) Investors
CareTrust REIT (CTRE) recently increased its quarterly dividend from US$0.335 to US$0.39 per share, signaling management's commitment to returning cash to shareholders. This dividend hike is supported by a US$1.0 billion equity offering and recent acquisitions, reinforcing the REIT's income-focused appeal. However, investors should consider the integration and reimbursement risks associated with its rapid portfolio expansion.
CareTrust REIT, Inc. (NYSE:CTRE) Increases Dividend to $0.39 Per Share
CareTrust REIT, Inc. (NYSE:CTRE) announced a quarterly dividend increase to $0.39 per share, up 16.4% from its previous $0.34. The dividend, payable on April 15th to shareholders of record on March 31st, implies a 3.9% yield. Despite a healthy payout ratio of 87.6% and recent earnings per share of $0.50 (beating estimates), the company's dividend coverage could be at risk if future earnings decline.
Assessing CareTrust REIT (CTRE) Valuation After Its Higher Dividend And Growth Confidence
CareTrust REIT (CTRE) recently approved a higher quarterly dividend, increasing it from $0.335 to $0.39 per share, following a strong share price performance and significant total shareholder return over the past year. The company is currently considered 8.5% undervalued with a fair value estimate of $43.82, supported by an expanded investment pipeline of approximately $600 million in skilled nursing, seniors housing, and U.K. care homes, which bolsters future FFO and dividend growth. However, this positive outlook is balanced by potential risks related to rapid portfolio expansion, increased G&A spending, and regulatory shifts in the healthcare sectors it operates in.
CareTrust REIT Raises Quarterly Dividend to $0.39 per Share
CareTrust REIT, Inc. announced that its Board of Directors has increased its quarterly common stock cash dividend from $0.335 to $0.39 per common share. The dividend will be payable to stockholders of record as of March 31, 2026, and is expected to be paid on or about April 15, 2026. CEO Dave Sedgwick stated that the increase reflects the company's commitment to delivering stockholder value and confidence in its portfolio and continued growth.
CareTrust REIT (CTRE) Boosts Dividend to 39 Cents Per Share
CareTrust REIT (CTRE) has announced an increase in its quarterly cash dividend from 33.5 cents to 39 cents per share, to be paid around April 15 to stockholders of record as of March 31. The company, a significant player in healthcare real estate, demonstrates strong profitability and a solid balance sheet, benefiting from an aging population. While financial health is robust, investors should consider the high dividend payout ratio and current valuation metrics.
Schroder Investment Management Group Acquires 410,532 Shares of CareTrust REIT, Inc. $CTRE
Schroder Investment Management Group significantly increased its stake in CareTrust REIT (CTRE) in Q3 by purchasing an additional 410,532 shares, bringing its total to 771,211 shares valued at $26.21 million. CareTrust REIT has received multiple analyst upgrades, holds a consensus "Buy" rating with an average target price of $41.27, and recently beat quarterly EPS estimates while issuing positive FY2026 guidance. The company also declared a $1.34 annualized dividend, representing a 3.3% yield, though its payout ratio is relatively high.
CareTrust REIT Raises Quarterly Dividend to $0.39 per Share
CareTrust REIT, Inc. announced that its Board of Directors has increased the quarterly common stock cash dividend from $0.335 to $0.39 per common share. This dividend will be payable to stockholders of record as of March 31, 2026, and is expected to be paid around April 15, 2026. CEO Dave Sedgwick stated that the increase reflects the company's commitment to delivering stockholder value and confidence in its portfolio and future growth.
CareTrust REIT raises quarterly dividend 16% to $0.39 per share
CareTrust REIT (NYSE:CTRE) has increased its quarterly common stock cash dividend by 16% to $0.39 per share, marking its tenth consecutive year of dividend increases. The company's CEO, Dave Sedgwick, expressed confidence in the portfolio's strength and continued growth. This news follows a mixed Q4 2025 earnings report where EPS missed forecasts but revenue exceeded expectations, along with significant acquisitions totaling $1.8 billion in 2025.
Russell Investments Group Ltd. Purchases 384,248 Shares of CareTrust REIT, Inc. $CTRE
Russell Investments Group Ltd. significantly increased its stake in CareTrust REIT, Inc. by purchasing 384,248 additional shares, bringing their total holdings to 1,286,396 shares valued at approximately $44.
[ARS] CareTrust REIT, Inc. SEC Fi... | CTRE SEC Filing - Form ARS
This article announces an SEC filing (Form ARS) by CareTrust REIT, Inc. (CTRE). The filing, dated March 13, 2026, has a low impact and neutral sentiment. The article also provides recent news, SEC filings, and stock data for CareTrust REIT, Inc.
41,500 Shares in CareTrust REIT, Inc. $CTRE Acquired by WINTON GROUP Ltd
WINTON GROUP Ltd has acquired 41,500 shares of CareTrust REIT (NASDAQ:CTRE) in the third quarter, valued at approximately $1.44 million. This acquisition is part of a broader trend of institutional investors increasing their stakes in CTRE, with major additions from Vanguard Group Inc., State Street Corp, Geode Capital Management LLC, Invesco Ltd., and Dimensional Fund Advisors LP. Analysts currently rate CareTrust REIT as a "Moderate Buy" with an average price target of $40.18, with several firms raising their targets to between $40-$43.
Vestcor Inc Purchases 54,489 Shares of CareTrust REIT, Inc. $CTRE
Vestcor Inc increased its stake in CareTrust REIT, Inc. (NASDAQ:CTRE) by 26.9% in the 3rd quarter, acquiring an additional 54,489 shares, bringing its total ownership to 256,706 shares valued at $8.9 million. Other institutional investors like Royal Bank of Canada and Envestnet Asset Management Inc. also increased their positions in the real estate investment trust. Analysts have set new price targets for CTRE, with an average rating of "Moderate Buy" and an average price target of $40.18.
CareTrust REIT, Inc. $CTRE Stake Reduced by Victory Capital Management Inc.
Victory Capital Management Inc. reduced its stake in CareTrust REIT by 5.8% in Q3, selling 62,890 shares but still owning over a million shares valued at $35.4 million. Despite this reduction from one institution, other large investors have increased their positions. CareTrust REIT maintains a "Moderate Buy" consensus rating from Wall Street analysts with an average target price of $40.18, and the company recently declared a quarterly dividend of $0.335 per share.
American Century Companies Inc. Reduces Stake in CareTrust REIT, Inc. $CTRE
American Century Companies Inc. reduced its stake in CareTrust REIT (NASDAQ:CTRE) by 6.6% in Q3, selling 49,388 shares. Despite this, institutional ownership remains high at 87.77%, with Vanguard Group Inc. significantly increasing its position. Analysts maintain a "Moderate Buy" rating for CTRE, with an average price target of $40.18, and the REIT offers a 3.4% dividend yield.
CareTrust REIT prices 20M share offering at $32 per share
CareTrust REIT announced the pricing of its offering of 20 million shares at $32 per share. The offering is expected to generate gross proceeds of $640 million, before accounting for underwriting discounts and other expenses. The company has also granted underwriters a 30-day option to purchase up to an additional 3 million shares.
CareTrust REIT, Inc. Experiences Valuation Adjustment Reflecting Shift in Financial Standing
CareTrust REIT, Inc. has recently adjusted its valuation, characterized by a P/E ratio of 36 and an exceptionally high dividend yield of 159.90%. The company demonstrates competitive performance with an 8.06% return on capital employed and maintains a strong market position within the realty sector compared to its peers. This valuation revision highlights its robust financial standing and performance against industry counterparts.
Fitch Ratings reaffirms ratings for CareTrust, NHI, Omega, Sabra
Fitch Ratings has reaffirmed the ratings for four real estate investment trusts (REITs) active in senior living and care: CareTrust, NHI, Omega Healthcare Investors, and Sabra Health Care REIT. This decision follows Fitch's update to its corporate rating criteria and sector navigators addendum, with the ratings and outlooks remaining unaffected by these changes. The reaffirmed ratings are supported by factors like demographic tailwinds, low leverage, strong financial flexibility, and improving operational profiles for each REIT.
Assessing CareTrust REIT’s (CTRE) Valuation After Earnings Beat And Expansion Into UK Care Properties
CareTrust REIT (CTRE) recently surpassed analyst earnings and revenue expectations and expanded its healthcare property portfolio in the U.S. and U.K. Trading at US$39.29, compared to a fair value estimate of US$43.55, the company appears undervalued. This positive outlook is supported by strategic acquisitions and international expansion, though potential risks exist if integration efforts falter or G&A expenses pressure FFO.
CareTrust REIT, Inc. $CTRE Stake Reduced by Segall Bryant & Hamill LLC
Segall Bryant & Hamill LLC significantly reduced its stake in CareTrust REIT (CTRE) by 19.9% in the third quarter, selling 143,575 shares and now holding 579,152 shares valued at approximately $20.09 million. Despite this reduction, institutional ownership remains high at 87.77%, with several other funds making modest adjustments to their positions. CareTrust REIT offers a quarterly dividend of $0.335 and has a "Moderate Buy" consensus rating from analysts, with a target price around $40.18.
